EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Endoscopic submucosal dissection for gastric neuroendocrine neoplasms: A multicenter retrospective study

Nikolaos Lazaridis, Alessandro Rimondi, Rocio Chacchi‐Cahuin, Arnaud Lemmers, Deborah Costa, Ana‐Maria Bucalau, Dalvinder Mandair, Sunil Gupta, Marcel Tantau, Mathieu Pioche, Jérôme Rivory, João Santos‐Antunes, Margarida Marques, Felipe Ramos Zabala, Federico Barbaro, Pedro Pimentel‐Nunes, Hugo Uchima, Eduardo Albeniz, Mario Dinis‐Ribeiro, Guido Costamagna, Cristiano Spada, Michael Bourke, Martyn Caplin, Christos Toumpanakis, Edward J. Despott, Alberto Murino

Journal of Neuroendocrinology · 2025-09 · 37 (9)

DOI: 10.1111/jne.70064 ↗
AbstractBibliografische Angaben

Abstract

Abstract Endoscopic submucosal dissection (ESD) has been reported as a feasible and effective treatment for Gastric Neuroendocrine Tumors (G‐NETs). However, most of the experience comes from retrospective tertiary centers in Eastern Asia. Data coming from western centers are lacking. This is a retrospective study, including patients who underwent endoscopic resection of G‐NETs by ESD between 2010 and 2020 in Western Centers. Important clinical variables such as demographic, size, type, presence of lymphovascular invasion or distant metastasis, completeness of the endoscopic resection, recurrence, and procedure‐related complications were recorded. Seventy‐three ESD procedures on G‐NETs from 69 patients from 11 centers were included. Median G‐NETs size on endoscopy was 12 mm (IQR 10–15). Case mix accounted for 83.6% type 1, 15.1% type 3, and 1.4% type 2. En‐bloc resection was possible in 69 procedure 94.5%, R0 resection rate stood at 79.5%. Five patients (7.2%) were referred for additional surgical intervention. One case of perforation was reported (1.4%), treated endoscopically. Three patients (4.4%) had evidence of recurrence during follow‐up. ESD is an effective and safe treatment for G‐NETs in western centers.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →